GlassScriptPhysician profile
Bibi T Sattar
NPI 1477728079
$3,468.16
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,874 · 2020: $840 · 2021: $506 · 2022: $248.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $727.27 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $493.90 | 2019-2020 | |
| Amarin Pharma, INC. | $395.07 | 2019-2021 | |
| Abbvie INC. | $377.83 | 2019-2021 | |
| Lilly USA, LLC | $252.89 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $196.10 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $155.39 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.20 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $108.16 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.93 | 2019-2021 | |
| Glaxosmithkline, LLC. | $97.73 | 2019-2021 | |
| Allergan, INC. | $70.05 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $58.02 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $47.53 | 2019 | |
| Mannkind Corporation | $46.73 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $44.45 | 2019 | |
| Pfizer INC. | $36.87 | 2019-2021 | |
| Medtronic Minimed, INC. | $35.14 | 2019 | |
| Ibsa Pharma INC. | $28.45 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $26.94 | 2019-2020 | |
| Dexcom, INC. | $17.09 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.18 | 2021 | |
| Alfasigma USA, INC. | $14.90 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $11.75 | 2019 | |
| Qol Medical, LLC | $2.59 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bibi Sattar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.